<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Viridiflorol (
 <bold class="bold">2</bold>) was previously isolated, as the major component, from the essential oils obtained from 
 <italic class="italic">Cistus ladaniferus</italic> L. [
 <xref rid="B27-pharmaceuticals-11-00033" ref-type="bibr" class="xref">27</xref>], “niaouli” (
 <italic class="italic">Melaleuca viridiflora</italic>, 
 <italic class="italic">M. quinquenervia</italic>) [
 <xref rid="B24-pharmaceuticals-11-00033" ref-type="bibr" class="xref">24</xref>,
 <xref rid="B48-pharmaceuticals-11-00033" ref-type="bibr" class="xref">48</xref>], and the liverwort 
 <italic class="italic">Bazzania trilobata</italic> L. [
 <xref rid="B49-pharmaceuticals-11-00033" ref-type="bibr" class="xref">49</xref>]. It has also been synthesized via (-)-alloaromadendrene [
 <xref rid="B26-pharmaceuticals-11-00033" ref-type="bibr" class="xref">26</xref>]. Viridiflorol (
 <bold class="bold">2</bold>) showed antifungal activity against 
 <italic class="italic">C. cucumerinum</italic> and 
 <italic class="italic">P. oryzae</italic> [
 <xref rid="B26-pharmaceuticals-11-00033" ref-type="bibr" class="xref">26</xref>,
 <xref rid="B49-pharmaceuticals-11-00033" ref-type="bibr" class="xref">49</xref>].
</p>
